Ad is loading...
ACLX
Price
$87.22
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
118 days until earnings call
BEAM
Price
$23.58
Change
-$0.91 (-3.72%)
Updated
Nov 21 closing price
102 days until earnings call
Ad is loading...

ACLX vs BEAM

Header iconACLX vs BEAM Comparison
Open Charts ACLX vs BEAMBanner chart's image
Arcellx
Price$87.22
Change-$0.00 (-0.00%)
Volume$345.14K
CapitalizationN/A
Beam Therapeutics
Price$23.58
Change-$0.91 (-3.72%)
Volume$1.01M
CapitalizationN/A
ACLX vs BEAM Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACLX vs. BEAM commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Sell and BEAM is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ACLX: $87.22 vs. BEAM: $23.58)
Brand notoriety: ACLX and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 56% vs. BEAM: 94%
Market capitalization -- ACLX: $4.72B vs. BEAM: $2.03B
ACLX [@Biotechnology] is valued at $4.72B. BEAM’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while BEAM’s TA Score has 3 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 5 bearish.
  • BEAM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than BEAM.

Price Growth

ACLX (@Biotechnology) experienced а -8.27% price change this week, while BEAM (@Biotechnology) price change was -10.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

BEAM is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.72B) has a higher market cap than BEAM($2.03B). ACLX YTD gains are higher at: 57.153 vs. BEAM (-13.373). ACLX has higher annual earnings (EBITDA): -33.12M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. ACLX (574M). ACLX has less debt than BEAM: ACLX (65.3M) vs BEAM (162M). BEAM has higher revenues than ACLX: BEAM (350M) vs ACLX (156M).
ACLXBEAMACLX / BEAM
Capitalization4.72B2.03B233%
EBITDA-33.12M-160.83M21%
Gain YTD57.153-13.373-427%
P/E RatioN/AN/A-
Revenue156M350M45%
Total Cash574M926M62%
Total Debt65.3M162M40%
TECHNICAL ANALYSIS
Technical Analysis
ACLXBEAM
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
89%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETCG12.711.01
+8.63%
Grayscale Ethereum Classic Trust (ETC)
DYLG29.810.31
+1.07%
Global X Dow 30 Covered Call & GrowthETF
XSEP38.790.07
+0.18%
FT Cboe Vest U.S. Eq Enh & ModBufETF-Sep
IVLU27.67N/A
N/A
iShares Edge MSCI Intl Value Factor ETF
EFZ16.65-0.03
-0.21%
ProShares Short MSCI EAFE

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
N/A
BEAM - ACLX
49%
Loosely correlated
-3.72%
RCKT - ACLX
48%
Loosely correlated
-1.92%
RCUS - ACLX
47%
Loosely correlated
-2.33%
MGTX - ACLX
46%
Loosely correlated
+1.72%
CRSP - ACLX
46%
Loosely correlated
-2.05%
More